ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Virginia » Geriatric Medicine

Top Geriatric Medicine Prescribers in Virginia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
WILLIAM HOVLAND MD

Geriatric Medicine

28,881

$1.95M

721
646 are 65+

7%
patients receiving schedule two controlled substances

Avg: 9%

4%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$67
Average prescription price

Avg: $56

CHRISTOPHER WEBB MD

Geriatric Medicine

27,706

$1.87M

912
800 are 65+

5%
patients receiving schedule two controlled substances

Avg: 9%

7%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$68
Average prescription price

Avg: $56

FOLA OLUWEHINMI MD

Geriatric Medicine

19,155

$1.11M

580
565 are 65+

5%
patients receiving schedule two controlled substances

Avg: 9%

19%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $56

WAYNE REYNOLDS M.D.

Geriatric Medicine

14,900

$647K

519
418 are 65+

3%
patients receiving schedule two controlled substances

Avg: 9%

9%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$43
Average prescription price

Avg: $56

ROBERT WALTERS MD

Geriatric Medicine

12,050

$728K

301
274 are 65+

10%
patients receiving schedule two controlled substances

Avg: 9%

11%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$60
Average prescription price

Avg: $56

NICOLE PADMORE MD

Geriatric Medicine

10,912

$668K

313
275 are 65+

12%
patients receiving schedule two controlled substances

Avg: 9%

15%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$61
Average prescription price

Avg: $56

VERNA SELLERS MD

Geriatric Medicine

10,427

$3,409

120
104 are 65+

15%
patients receiving schedule two controlled substances

Avg: 9%

26%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$0
Average prescription price

Avg: $56

JONATHAN EVANS M.D.

Geriatric Medicine

10,220

$405K

310
275 are 65+

19%
patients receiving schedule two controlled substances

Avg: 9%

17%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$40
Average prescription price

Avg: $56

NALINI MORISHETTY M.D.

Geriatric Medicine

9,437

$623K

217
205 are 65+

14%
patients receiving schedule two controlled substances

Avg: 9%

15%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$66
Average prescription price

Avg: $56

JEANNE ROLL MD

Geriatric Medicine

8,914

$434K

441
309 are 65+

3%
patients receiving schedule two controlled substances

Avg: 9%

8%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $56

KISHOR DABHI M.D.

Geriatric Medicine

6,622

$347K

348
286 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $56

JENNIFER JONKERS M.D.

Geriatric Medicine

6,525

$333K

426
318 are 65+

7%
patients receiving schedule two controlled substances

Avg: 9%

13%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $56

CHERIAN JOSEPH M.D.

Geriatric Medicine

6,340

$403K

167
113 are 65+

31%
patients receiving schedule two controlled substances

Avg: 9%

28%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$64
Average prescription price

Avg: $56

BHARATI SRIVASTAVA M.D.

Geriatric Medicine

5,349

$329K

362
355 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

9%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $56

HAMID OKHRAVI MD

Geriatric Medicine

5,234

$327K

148
147 are 65+

14%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$63
Average prescription price

Avg: $56

KEVIN MURRAY M. D.

Geriatric Medicine

5,079

$336K

368
314 are 65+

4%
patients receiving schedule two controlled substances

Avg: 9%

7%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$66
Average prescription price

Avg: $56

MARK NEWBROUGH M.D.

Geriatric Medicine

4,996

$306K

199
195 are 65+

6%
patients receiving schedule two controlled substances

Avg: 9%

26%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$61
Average prescription price

Avg: $56

PETER BOLING MD

Geriatric Medicine

4,758

$246K

320
288 are 65+

10%
patients receiving schedule two controlled substances

Avg: 9%

8%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $56

VIJAY CHADHA MD

Geriatric Medicine

4,689

$271K

295
262 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $56

SEKI BALOGUN M.D.

Geriatric Medicine

4,610

$261K

246
239 are 65+

6%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $56

GREG CORINALDI M.D.

Geriatric Medicine

4,068

$269K

352
313 are 65+

5%
patients receiving schedule two controlled substances

Avg: 9%

5%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$66
Average prescription price

Avg: $56

DIANE SNUSTAD M.D.

Geriatric Medicine

3,840

$233K

213
209 are 65+

10%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$61
Average prescription price

Avg: $56

SARAH HOBGOOD MD

Geriatric Medicine

3,690

$169K

249
231 are 65+

12%
patients receiving schedule two controlled substances

Avg: 9%

7%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $56

ANURADHA REDDY MD

Geriatric Medicine

3,611

$209K

147
137 are 65+

21%
patients receiving schedule two controlled substances

Avg: 9%

7%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $56

HUAI CHENG M.D.

Geriatric Medicine

3,305

$148K

111
104 are 65+

14%
patients receiving schedule two controlled substances

Avg: 9%

15%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank